AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
16.6.2026 17:00:00 EEST | Business Wire | Press release
AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical’s next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616325248/en/
Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) acceleration and reconstruction software designed to support MRI speed, image quality and workflow performance. Healthcare organizations and leading academic institutions are adopting AIRS Medical's technologies to expand imaging capacity and improve patient access. Today, the Company supports more than 1,700 healthcare institutions across over 40 countries, with its AI technologies utilized in more than 6 million MRI examinations annually.
As healthcare providers increasingly look to improve imaging efficiency by optimizing existing infrastructure, AIRS Medical is uniquely positioned at the intersection of AI, medical imaging and healthcare operations to support their efforts. The Company’s AI-powered MRI acceleration and image enhancement solution (SwiftMR®), and an MRI quantification and structured reporting platform (SwiftSight®), offer healthcare organizations a unified solution from image acquisition through clinical interpretation.
"MRI scanners are among the most valuable assets in healthcare, yet many providers continue to struggle with growing imaging demand and limited capacity," said Dr. Hyeseong Lee, Co-Founder and Chairman of AIRS Medical. "We are pleased to partner with TA to further advance our mission to increase accessibility to advanced diagnostics and deliver greater value for patients and providers globally."
"This investment marks an important milestone in AIRS Medical's growth journey," said Jason Park, Chief Executive Officer of AIRS Medical. "Demand for technologies that improve MRI efficiency and expand patient access continues to grow globally. With TA's support, we will accelerate product innovation, expand our international footprint and continue helping healthcare providers unlock greater value from their existing MRI infrastructure.”
“As an AI-native medical technology leader, AIRS Medical has developed a differentiated AI platform that addresses critical capacity and workflow challenges facing radiology providers globally,” said Edward Sippel, Managing Director and head of TA Asia Pacific. “The Company’s strong foundation and growing international presence across 40+ countries position it well to meet increasing demand for solutions that improve imaging efficiency, patient access and diagnostic consistency.”
“TA has a long history of partnering with innovative healthcare technology companies that help providers deliver better patient outcomes,” said Michele Lim, Senior Vice President, TA. “We are excited to partner with the entire AIRS Medical team as they build on their strong momentum, expand their market leadership and continue delivering meaningful value to providers and patients worldwide.”
Financial terms of the transaction were not disclosed. The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions.
About AIRS Medical
AIRS Medical is a global AI medical imaging company transforming MRI through deep learning. Its solutions, SwiftMR® and SwiftSight®, are deployed at leading health systems and imaging networks worldwide. SwiftMR® is FDA-cleared, CE-marked under MDR, and approved by Korea's MFDS, Japan's PMDA, and other regulatory authorities across 40+ countries. Learn more at airsmed.com.
About TA
TA is a leading global private equity firm focused on scaling growth in profitable companies. Since 1968, TA has invested in more than 560 companies across its core sectors, including technology, business services, financial services, and healthcare. Leveraging its deep industry expertise and strategic resources, TA collaborates with management teams worldwide to help high-quality companies deliver lasting value. The firm has raised $65 billion in capital to date and has more than 160 investment professionals across offices in Boston, Menlo Park, Austin, London, Mumbai, and Hong Kong. Learn more at www.ta.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260616325248/en/
Contacts
Media Contact
TA Associates
Brynn Sandy
media@ta.com
617-646-7703
AIRS Medical
Jina Park
media@airsmed.com
847-220-6369
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Happy Holidays S.A. and JTA Investment Holding Announce €65 Million Investment for SARTIMARE Tourism Development in Greece16.6.2026 18:42:00 EEST | Press release
Happy Holidays S.A. today announced the signing of an Investment Agreement with Qatar-based JTA Investment Holding for the development of the sustainable SARTIMARE Beach Resort & Spa project in Sarti, Halkidiki, Greece. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616892834/en/ Dr. Amir Ali Salemi Zadeh, CEO of JTA Investment Holding and Georgios Iosifidis, Founder & Owner of Happy Holidays S.A. Under the agreement, JTA Investment Holding will invest €65 million into the development. The project will be built on a site of approximately 120,900 square meters, with construction scheduled between 2027 and 2030. Designed with a strong commitment to environmental responsibility, the SARTIMARE project will feature luxury hospitality facilities, premium residences and villas, wellness amenities, retail, food & beverage outlets, and marina infrastructure. The project's valuation is expected to exceed €100 million as key develop
IFF and ISIPCA Mark 10 Years of Joint Scent Design and Creation Master’s-Level Program16.6.2026 18:00:00 EEST | Press release
IFF — a global leader in flavors, fragrances, food ingredients and health & biosciences — celebrates the 10th anniversary of its industry-leading accredited master's-level program for scent design and creation, developed in partnership with ISIPCA, the world-renowned school for careers in perfume, cosmetics and food flavors. Since its launch in 2016, the IFF ISIPCA program has trained more than 180 professionals from 40 countries, with 130 graduates to date, and a 100% job landing rate up to six months after graduation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615461626/en/ The IFF ISIPCA Scent Design and Creation program has been pioneering fragrance education and excellence since 2016. “Over the past decade, IFF ISIPCA has built a strong pipeline of diverse, high-potential fragrance experts, combining creative excellence, scientific expertise and a global perspective,” says Valery Claude, program sponsor and senio
Fenchurch Advisory Partners to Combine With Broadhaven Capital Partners, Creating the Preeminent International Investment Bank Serving the Financial Services Sector16.6.2026 17:30:00 EEST | Press release
Fenchurch Advisory Partners has entered into a definitive agreement to combine with Broadhaven Capital Partners, a leading independent advisory firm to the financial technology and financial services sectors in North America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616214669/en/ Fenchurch is one of the most respected investment banking advisory firms dedicated exclusively to the financial services sector. With offices in London, New York and Paris, Fenchurch provides trusted, independent advice to corporates and financial sponsors across insurance, asset and wealth management, banking, and specialty finance. In 2025, Fenchurch advised on 27 transactions, ranking as the number one adviser to the financial services sector in the UK and Europe. Founded in 2009, Broadhaven has established itself as a premier investment bank advising corporates and financial sponsors on M&A, capital raising, and strategic transactions,
Svante’s Solid Sorbent Filter Technology Named to Fast Company’s 2026 World Changing Ideas Awards List16.6.2026 17:00:00 EEST | Press release
Svante Technologies Inc. (Svante), a purpose-driven integrated carbon management company, today announced that its nanoengineered solid sorbent filter technology has been named to Fast Company’s 2026 World Changing Ideas list, one of the world’s most selective recognitions for innovations tackling climate and sustainability challenges. The honour recognizes Svante’s proprietary filter platform, which enables high-performance capture and removal of CO₂ from industrial emissions and the air, as well as other critical gas separation applications, particularly where chemical processes do not perform well. This year’s awards, featured on fastcompany.com, highlight 191 outstanding projects across 14 categories. A panel of Fast Company editors and reporters evaluated more than 1,500 entries based on their impact, sustainability, design, creativity, scalability, and ability to improve society. “This recognition underscores the commercial and societal importance of Svante’s approach to carbon c
Gurobi's Research Leadership Recognized Across Leading Scientific Organizations16.6.2026 16:00:00 EEST | Press release
Gurobi Optimization, LLC, the leader in decision intelligence technology, today announced recognitions received by Dr. Edward Rothberg and Dr. Andreas Wächter from leading academic and industry organizations for research that has had lasting impact on the field of optimization. “Gurobi was founded on a commitment to rigorous, applied optimization research,” said Dr. Oliver Bastert, CTO, Gurobi. “And these recognitions are a reflection of that legacy. The foundational work that Ed and Andreas produced continues to shape the field, and that same spirit of scientific innovation drives everything we do today.” Dr. Edward Rothberg, co-founder and Chairman of the Board at Gurobi, was recently honored with the INFORMS Test of Time Paper Award for his paper, “An Evolutionary Algorithm for Polishing Mixed Integer Programming Solutions.” The paper introduced a novel approach to finding high-quality solutions to difficult MIP problems — expanding what was possible within the MIP framework and inf
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom